| 000 | 01224 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516201911.0 | ||
| 264 | 0 | _c20140310 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a2044-5385 | ||
| 024 | 7 |
_a10.1038/bcj.2014.8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTobiasson, M | |
| 245 | 0 | 0 |
_aLimited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial. _h[electronic resource] |
| 260 |
_bBlood cancer journal _cMar 2014 |
||
| 300 |
_ae189 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aDybedahl, I | |
| 700 | 1 | _aHolm, M S | |
| 700 | 1 | _aKarimi, M | |
| 700 | 1 | _aBrandefors, L | |
| 700 | 1 | _aGarelius, H | |
| 700 | 1 | _aGrövdal, M | |
| 700 | 1 | _aHögh-Dufva, I | |
| 700 | 1 | _aGrønbæk, K | |
| 700 | 1 | _aJansson, M | |
| 700 | 1 | _aMarcher, C | |
| 700 | 1 | _aNilsson, L | |
| 700 | 1 | _aKittang, A O | |
| 700 | 1 | _aPorwit, A | |
| 700 | 1 | _aSaft, L | |
| 700 | 1 | _aMöllgård, L | |
| 700 | 1 | _aHellström-Lindberg, E | |
| 773 | 0 |
_tBlood cancer journal _gvol. 4 _gp. e189 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bcj.2014.8 _zAvailable from publisher's website |
| 999 |
_c23621925 _d23621925 |
||